HepQuant
HepQuant has developed noninvasive, blood-based, quantitative tests that assess liver health by
measuring critical liver cell processes and blood flow to the liver. HepQuant’s mission and vision
is driven by our commitment to transform the management of liver disease. Our test results, in
conjunction with other clinical assessments, inform healthcare providers’ clinical decisions to
achieve more effective management of patients with advanced liver disease. Sample analysis is
limited to use only in the CAP accredited, CLIA certified HepQuant Analytical Testing Laboratory.
HepQuant is a privately-held diagnostics company based in Denver, Colorado.
